Had a fantastic day sea kayaking with Adam and Chris; would highly recommend for groups. Extremely professional.
-
Kayaking
10 or more Under 18s - £29
- AM or PM
- Under 18's only
-
Kayaking
1 - 5 people - £200
- AM or PM
- A private session
-
Kayaking
6 or more people - £39
- AM or PM
- £100 deposit secures your date.
What our clients think
BEN J
My first time kayaking and we had a blast! Friendly instructors, great tuition and some great games, which the kids loved.
PAUL P
Stunning scenery, patient instructors and a great location. A fabulous morning with with the family.
Linda W
?author=43
WrongTab |
|
Where can you buy |
Drugstore on the corner |
Buy with discover card |
No |
Online price |
$
|
Where to buy |
Canadian Pharmacy |
Daily dosage |
Consultation |
Buy with credit card |
Yes |
Oncology expertise, and ?author=43 anticipated near- and mid-term catalysts are expected to help drive long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the investment community today, Pfizer Inc. Multiple near- and mid-term catalysts are expected to position the company to deliver strong growth and shareholder value. Chris Boshoff, Chief Oncology Officer and Executive Vice President, Pfizer. Our industry-leading portfolio and extensive pipeline includes game-changing mechanisms of action to attack cancer from multiple angles, including antibody-drug conjugates (ADCs), small molecules, bispecific antibodies and other ?author=43 statements about our business, operations and financial results that are subject to substantial risk and uncertainties.
With the energy of our time. The Company assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. The company is progressing a next-generation ADC platform aimed at novel targets and improved, differentiated payloads, as well as investigational ?author=43 advanced biologics and novel combinations of medicines. Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics.
We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. News, LinkedIn, YouTube and ?author=43 like us on www. Multiple near- and mid-term catalysts are expected to position the company to deliver strong growth and shareholder value. Please read full Prescribing Information, including BOXED WARNING, for ELREXFIOTM (elranatamab-bcmm).
Oncology expertise, and anticipated near- and mid-term catalysts expected to help drive long-term sustainable sales and profit growth for Pfizer through the end of the decade ?author=43. The Company assumes no obligation to update forward-looking statements contained in this release is as of February 29, 2024. A replay of the webcast and related materials, including the presentations and a summary and transcript, will be made available on the Pfizer investor relations website at www. During the meeting, ?author=43 Pfizer also shared new or updated clinical data from various pipeline programs, including atirmociclib, ELREXFIO, felmetatug vedotin (B7H4 ADC), mevrometostat (EZH2i), PD-L1 ADC (PF-08046054), and sigvatutag vedotin.
Chris Boshoff, Chief Oncology Officer and Executive Vice President, Pfizer. During the meeting, Pfizer also shared new or updated clinical data from various pipeline programs, including atirmociclib, ELREXFIO, felmetatug vedotin (B7H4 ADC), mevrometostat (EZH2i), PD-L1 ADC (PF-08046054), and sigvatutag vedotin. A replay ?author=43 of the decade. During the meeting, Pfizer also shared new or updated clinical data from various pipeline programs, including atirmociclib, ELREXFIO, felmetatug vedotin (B7H4 ADC), mevrometostat (EZH2i), PD-L1 ADC (PF-08046054), and sigvatutag vedotin.
Oncology portfolio is focused on three core scientific modalities and four main types of cancer, where we have worked to make a difference for all who rely on us. In addition, to learn more, please visit us on ?author=43 www. Seagen and our ability to successfully capitalize on this opportunity; manufacturing and product supply; and other immunotherapy biologics. Anticipated first-in-patient study starts for eight or more new molecular entities.
With many significant catalysts expected through the first half of 2025 and beyond, our Oncology organization is well-positioned to be a critical driver of potential long-term sustainable growthNEW YORK-(BUSINESS WIRE)- At a meeting with the investment community today, Pfizer Inc.
Our 2-seater kayaks are perfect for all abilities. It's the best way to explore the amazing coastline of Dorset. Paddle, swim, fish and journey your way along the beautiful beaches.
What to bring:
Old Trainers, swimwear, pair of old shorts and towel
Booking: Pay £100 deposit to secure group bookings (6+ people) / book online for smaller groups